Merit Medical Systems, Inc.
MMSI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $384 | $382 | $355 | $355 |
| % Growth | 0.4% | 7.6% | 0.1% | – |
| Cost of Goods Sold | $198 | $198 | $183 | $182 |
| Gross Profit | $186 | $184 | $172 | $173 |
| % Margin | 48.5% | 48.2% | 48.4% | 48.7% |
| R&D Expenses | $24 | $24 | $22 | $25 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $120 | $113 | $107 | $108 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $3 |
| Operating Expenses | $144 | $138 | $131 | $136 |
| Operating Income | $43 | $47 | $41 | $37 |
| % Margin | 11.1% | 12.3% | 11.5% | 10.3% |
| Other Income/Exp. Net | -$4 | -$4 | -$3 | -$3 |
| Pre-Tax Income | $39 | $43 | $38 | $33 |
| Tax Expense | $11 | $11 | $8 | $5 |
| Net Income | $28 | $33 | $30 | $28 |
| % Margin | 7.2% | 8.5% | 8.5% | 7.9% |
| EPS | 0.47 | 0.55 | 0.51 | 0.48 |
| % Growth | -14.5% | 7.8% | 6.3% | – |
| EPS Diluted | 0.46 | 0.54 | 0.49 | 0.46 |
| Weighted Avg Shares Out | 59 | 59 | 59 | 59 |
| Weighted Avg Shares Out Dil | 60 | 61 | 61 | 61 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $4 | $4 | $5 |
| Interest Expense | $7 | $7 | $7 | $8 |
| Depreciation & Amortization | $34 | $34 | $32 | $32 |
| EBITDA | $80 | $84 | $77 | $73 |
| % Margin | 20.7% | 22% | 21.6% | 20.5% |